Preventing Antimicrobial Resistance in Hospitals: Infection Control and Antibiotic Use

Dear Colleagues,

The growing issue of antimicrobial resistance (AMR) poses one of the most formidable challenges to public health. Hospitals, where most patients reside and where antimicrobial agents are most frequently used, are critical places in this silent pandemic. Central to this crisis is the intricate balance between the necessity of antibiotic use and the imperative to minimize the development of resistance.

In this Special Issue, we aim to delve into the multifaceted strategies required to combat AMR within healthcare settings. Our aim is to explore this balance and offer insights into effective infection control practices, stewardship programs, and innovative approaches to antibiotic use. Key topics include, but are not limited to, the following:

• Infection Control Measures: Highlighting the critical importance of hygiene practices, surveillance systems, and outbreak management protocols and underscoring infection prevention guidelines to curb the spread of resistant pathogens within hospitals.
• Optimizing Antibiotic Use: Presenting evidence-based strategies, including the implementation of stewardship programs, education and training of healthcare professionals, and the development of policies that promote the judicious use of antimicrobials.
• Research and Technological Advancements: Bringing attention to cutting-edge research and technological advancements that promise to enhance our ability to detect, monitor, and combat AMR. This includes rapid diagnostic tools for the precise and timely identification of pathogens, as well as the development of new antimicrobial agents and alternative therapies.
• Understanding AMR: Investigating the mechanisms, causes, and consequences of clinical antimicrobial resistance to develop effective strategies to mitigate its impact.

We look forward to receiving your contributions.

Prof. Dr. Dorota Pastuszak-Lewandoska
Dr. Filip Bielec
Dr. Małgorzata Brauncajs
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.